These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28977808)

  • 41. Efficacy and safety of pancreatic enzyme replacement therapy in pancreatic exocrine insufficiency: a systematic review protocol.
    Ooi YX; Nguyen NQ; Norton I; Campbell J
    JBI Database System Rev Implement Rep; 2016 Jan; 14(1):20-30. PubMed ID: 26878917
    [No Abstract]   [Full Text] [Related]  

  • 42. Romanian guidelines on the diagnosis and treatment of exocrine pancreatic insufficiency.
    Gheorghe C; Seicean A; Saftoiu A; Tantau M; Dumitru E; Jinga M; Negreanu L; Mateescu B; Gheorghe L; Ciocirlan M; Cijevschi C; Constantinescu G; Dima S; Diculescu M;
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):117-23. PubMed ID: 25822444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of a novel pancreatic enzyme product, EUR-1008 (Zenpep), in patients with exocrine pancreatic insufficiency due to chronic pancreatitis.
    Toskes PP; Secci A; Thieroff-Ekerdt R;
    Pancreas; 2011 Apr; 40(3):376-82. PubMed ID: 21343835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Not Available].
    Lenglinger J; Hädrich M
    Ther Umsch; 2016 Nov; 73(9):500-504. PubMed ID: 27805488
    [No Abstract]   [Full Text] [Related]  

  • 45. Pancreatic enzyme replacement therapy for people with cystic fibrosis (Review).
    Somaraju UR; Solis-Moya A
    Paediatr Respir Rev; 2015 Mar; 16(2):108-9. PubMed ID: 25497671
    [No Abstract]   [Full Text] [Related]  

  • 46. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy?
    Domínguez-Muñoz JE; Iglesias-García J
    JOP; 2010 Mar; 11(2):158-62. PubMed ID: 20208327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic enzyme replacement therapy during pancreatic insufficiency.
    Berry AJ
    Nutr Clin Pract; 2014 Jun; 29(3):312-21. PubMed ID: 24687867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancrelipase for pancreatic disorders: An update.
    Dhanasekaran R; Toskes PP
    Drugs Today (Barc); 2010 Nov; 46(11):855-66. PubMed ID: 21225024
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exocrine Pancreatic Insufficiency.
    Bitton S; Pettei MJ
    Pediatr Rev; 2016 Feb; 37(2):85-7. PubMed ID: 26834230
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations.
    Maev IV; Bideeva ТВ; Kucheryavyy YA; Andreev DN; Bueverov AO
    Ter Arkh; 2018 Aug; 90(8):81-85. PubMed ID: 30701942
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [PANCREATIC EXOCRINE INSUFFICIENCY AND ITS CORRECTION IN CHILDREN WITH TYPE I DIABETES IN COMBINATION WITH CELIAC DISEASE].
    Bolshova EV; Lukashuk IV; Lukashuk VD
    Lik Sprava; 2015; (1-2):167-9. PubMed ID: 26118067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 50 Years Ago in TheJournalofPediatrics: Exocrine Pancreas Insufficiency: Supplementing Our Way to Success.
    Murray KM; Oliveira SB
    J Pediatr; 2021 Apr; 231():49. PubMed ID: 33766300
    [No Abstract]   [Full Text] [Related]  

  • 53. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
    Aloulou A; Schué M; Puccinelli D; Milano S; Delchambre C; Leblond Y; Laugier R; Carrière F
    Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exocrine pancreatic insufficiency in a cat.
    Browning T
    Aust Vet J; 1998 Feb; 76(2):104-6. PubMed ID: 9578779
    [No Abstract]   [Full Text] [Related]  

  • 55. Less common etiologies of exocrine pancreatic insufficiency.
    Singh VK; Haupt ME; Geller DE; Hall JA; Quintana Diez PM
    World J Gastroenterol; 2017 Oct; 23(39):7059-7076. PubMed ID: 29093615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life.
    D'Haese JG; Ceyhan GO; Demir IE; Layer P; Uhl W; Löhr M; Rychlik R; Pirilis K; Zöllner Y; Gradl B; Foerster D; Möbius J; Henniges F; Friess H
    Pancreas; 2014 Aug; 43(6):834-41. PubMed ID: 24717829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimal size range for enteric-coated pancreatin preparations.
    Lederer PC
    Pancreas; 2011 Mar; 40(2):310-1. PubMed ID: 21311309
    [No Abstract]   [Full Text] [Related]  

  • 58. Review: Management of postprandial diarrhea syndrome.
    Money ME; Camilleri M
    Am J Med; 2012 Jun; 125(6):538-44. PubMed ID: 22624684
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [DELAYED RESULTS OF ENZYME REPLACEMENT THERAPY, PRESCRIBED BY RESULTS OF 13C-TRIGLYCERIDE BREATH TEST].
    Chernyavskiy VV; Gvozdetska LS
    Lik Sprava; 2015; (3-4):94-9. PubMed ID: 26827447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pancreatic exocrine insufficiency after pancreaticoduodenectomy is more prevalent with pancreaticogastrostomy than with pancreaticojejunostomy. A retrospective multicentre observational cohort study.
    Roeyen G; Jansen M; Ruyssinck L; Chapelle T; Vanlander A; Bracke B; Hartman V; Ysebaert D; Berrevoet F
    HPB (Oxford); 2016 Dec; 18(12):1017-1022. PubMed ID: 27726974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.